Concepedia

A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients

Pascal Vranckx, Freek W.A. Verheugt, Moniek PM de Maat, Victor Ulmans, Evelyn Regar, Peter Smits, Jurriën M. ten Berg, Wietze Lindeboom, Russel Jones, Jeffrey Friedman,

EuroIntervention · 2013 · 53 citations · 18 references

DOIFull text

Open access

Abstract

Dabigatran treatment (110 mg or 150 mg BID) may not provide sufficient anticoagulation during PCI. EudraCT. No: 2007-007536-25.

References

18

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.1K citations · Full text

Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate

Lesley A. Stevens, Josef Coresh, Tom Greene et al. · New England Journal of Medicine · 2006 · 2.9K citations

, , +13

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Sam Schulman, Clive Kearon, Ajay K. Kakkar et al. · New England Journal of Medicine · 2009 · 2.5K citations · Full text

Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

European Heart Journal · 2007 · 2.5K citations · Full text

, , +20

Bivalirudin during Primary PCI in Acute Myocardial Infarction

Gregg W. Stone, Bernhard Witzenbichler, Giulio Guagliumi et al. · New England Journal of Medicine · 2008 · 1.8K citations · Full text